# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Josephine Baker (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML049-SYN-TD
- Date: 1969-04-14
- Fictional facility: St. Posthumous Health Center
- Fictional author: Colette Ashby-Nwosu, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Establishing care three weeks after a heart attack and stent, with breathlessness on exertion and tiredness: examination, ECG, laboratory tests, medicines, mood screening, cardiac rehabilitation and the chest-pain action plan. **S**

## Historical basis

- She was born Freda Josephine McDonald on June 3, 1906, in St. Louis, Missouri, to Carrie McDonald and Eddie Carson, into a family with little money. **D**
- She grew up in poor neighborhoods of St. Louis and began working as a child; she married twice before the age of 16 and kept the surname of her second husband, William Howard Baker. **D**
- She danced in New York in the musicals Shuffle Along and The Chocolate Dandies, came to Paris with her troupe in 1925 to perform at the Théâtre des Champs-Elysées, and became the most famous and highest-paid American performer in France. **D**
- She married a Frenchman in 1937 and became a French citizen; the National Park Service gives 1936. **D**
- During the Second World War she worked for the intelligence services of Free France with the rank of sub-lieutenant, gathering information and carrying messages written in invisible ink on her sheet music; on August 18, 1961, she received the Legion of Honor and the Croix de guerre with palm. **D**
- She bought a château at Les Milandes in the Périgord, where she made a "village of the world" and raised twelve children of different nationalities and religions whom she had adopted during her tours with Jo Bouillon, her husband; the children were called the "Rainbow Tribe". **D**
- In North Africa during the war she was taken urgently to hospital in Casablanca, where she stayed in bed from June 1941 to December 1942, had five operations and was several times reported to be dying; she continued her intelligence work from her room. **D**
- The illness followed the loss of a pregnancy in 1941, given as a stillbirth in Casablanca by one source and as a miscarriage by another; the second account says a severe infection required a hysterectomy, after which she developed peritonitis and septicemia. La Croix says she was unable to have children. **R**
- At the March on Washington for Jobs and Freedom on August 28, 1963, she was one of the few women to speak; she came in her military uniform with her decorations. **D**
- Les Milandes ran into heavy debt; she toured repeatedly to pay it, and on June 2, 1964, she made a televised appeal for donations, saying her work no longer covered debts of about 200 million old francs. **D**
- In March 1969, after a court ordered her eviction, she was removed from the château and sat for seven hours in the rain on its steps; she had a new heart attack and ended the day in hospital in Périgueux. Les Milandes was sold at auction that year. **D**

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- She wants to return to the stage and to have the strength to care for her children. **S**
- She is afraid of another heart attack and of what would happen to her family. **S**
- Debts and lost income make every cost a worry. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- Aspirin 81 mg delayed-release oral tablet, one tablet daily **S**
- Ticagrelor 90 mg oral tablet, one tablet twice daily **S**
- Atorvastatin 80 mg oral tablet, one tablet daily **S**
- Metoprolol succinate 25 mg extended-release oral tablet, one tablet daily **S**
- Lisinopril 5 mg oral tablet, one tablet daily **S**
- Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if the pain is not better 5 minutes after the first tablet **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- June 1941 to December 1942: Long, grave illness in Casablanca after the loss of a pregnancy: in bed in hospital from June 1941 to December 1942, with five operations, reportedly including an emergency hysterectomy, and peritonitis and septicemia (details from one secondary source; stillbirth or miscarriage disputed) **R** (CLM-0007, CLM-0008)
- March 1969: Heart attack in March 1969, on the day of her eviction from Les Milandes, with admission to hospital in Périgueux; described as a new heart attack, with any earlier one undated in the sources read **D** (CLM-0011)

## Procedures and immunizations

- 1969-03-24 to 1969-03-24: Coronary angiography and percutaneous coronary intervention in the hospital for a non-ST-elevation myocardial infarction: 90% stenosis of the mid right coronary artery treated with one drug-eluting stent; mild disease elsewhere. Performed at a regional hospital before she established care **S**
- 1969-04-14 to 1969-04-14: Twelve-lead electrocardiogram: sinus rhythm at 64 per minute, small Q waves in II, III and aVF from the recent inferior infarction, no acute ST change, normal QT **S**


## Family history

- No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

## Measurements

Hemoglobin: 12.2 g/dL; Platelets: 264 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 0.82 mg/dL; eGFR (CKD-EPI 1964): 81 mL/min/1.73 m²; Glucose: 94 mg/dL; Total cholesterol: 152 mg/dL; LDL cholesterol: 84 mg/dL (high); HDL cholesterol: 52 mg/dL; Triglycerides: 80 mg/dL; ALT: 24 U/L; Hemoglobin A1c: 5.6%; PHQ-2: 2; PHQ-9: 7; Seattle Angina Questionnaire-7 summary: 70. All results are synthetic.

BP 138/84 mmHg; pulse 64 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 59.8 kg; BMI 21.2 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, warm and direct; worried about her family and her debts, and grieving the loss of her home; sleeps poorly; PHQ-9 score 7 with no thoughts of self-harm. Functional status: Independent in all daily activities; breathless after one flight of stairs or ten minutes of brisk walking, which before the heart attack never limited her; has not danced since. Physical examination is intentionally limited. **S**

## Assessment

1. Breathlessness on exertion and tiredness since discharge three weeks after the heart attack, without chest pain at rest; cause to be determined (heart function, ischemia, anemia, medicine effect or deconditioning); status draft. **S**
2. Coronary artery disease after a non-ST-elevation myocardial infarction three weeks before intake, treated with one drug-eluting stent to the right coronary artery; synthetic modern episode linked to the documented heart attack of March 1912; status draft. **S**
3. High blood pressure, found during the hospital stay for the heart attack; status draft. **S**
4. Absence of the uterus after an emergency hysterectomy at about 35, during a long, grave illness after the loss of a pregnancy; whether the ovaries were removed is not known; counted as a possible early menopause when weighing her cardiovascular risk; status draft. **S**
5. Financial strain: heavy debts after the loss of her home and estate, with income only from performing, which she has stopped while she recovers; status draft. **S**

## Plan

- Respectful, trauma-informed shared decisions: take her account of her symptoms seriously, explain each medicine and its reason plainly, write the plan down, and check costs with her before prescribing. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association (2016); Sex and Race/Ethnicity-Related Disparities in Care and Outcomes After Hospitalization for Coronary Artery Disease Among Older Adults (2016) **S**
- Cardiology consultation on the day of the two-week visit, with an echocardiogram, to find the cause of the breathlessness, review the antiplatelet choice and the other medicines, and advise on rehabilitation and a return to the stage. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes (2025); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and acute myocardial infarction monographs (2026) **S**
- Dual antiplatelet therapy, aspirin 81 mg with a P2Y12 inhibitor, for twelve months from the heart attack, never stopped without speaking to cardiology; then aspirin alone. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes (2025); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and acute myocardial infarction monographs (2026) **S**
- Atorvastatin 80 mg daily; lipid panel four to eight weeks after the start; goal LDL below 70 mg/dL with at least a 50% fall; lipoprotein(a) measured once. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and acute myocardial infarction monographs (2026) **S**
- Metoprolol succinate for at least the first year after the heart attack; lisinopril for high blood pressure, with home readings and a target below 130/80 mmHg; potassium and creatinine one to two weeks after any dose change. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and acute myocardial infarction monographs (2026) **S**
- Enroll in a 36-session outpatient cardiac rehabilitation program, starting within two weeks, with exercise training, nutrition, stress management and psychological support; the clinic will call her if she misses sessions. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association (2016); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and acute myocardial infarction monographs (2026) **S**
- Depression after a heart attack: PHQ-2 and PHQ-9 today, repeat PHQ-9 at about twelve weeks, the rehabilitation program's psychologist, and a lower threshold for treatment if symptoms rise. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); Depression and Coronary Heart Disease: Recommendations for Screening, Referral, and Treatment: A Science Advisory From the American Heart Association (2008); Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: A Scientific Statement From the American Heart Association (2014) **S**
- Chest-pain action plan: nitroglycerin under the tongue, and 911 if pain is not better five minutes after the first tablet; warning symptoms in women, such as breathlessness, unusual tiredness, nausea or jaw, back or arm discomfort, explained. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association (2016) **S**
- Costs: generic medicines in 90-day fills, the clinic social worker for debt advice and help with medicine costs, and rehabilitation sessions at times that fit her family. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023) **S**
- Women's cardiovascular risk: record the hysterectomy of her thirties and a possible early menopause as a risk-enhancing factor; hormone therapy is not used to prevent heart disease. Guideline: Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association (2016); Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association (2020) **S**

## Guideline basis

- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023), American Heart Association and American College of Cardiology (Circulation 2023;148(9):e9-e119)
- 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes (2025), American College of Cardiology and American Heart Association (Circulation 2025;151(13):e771-e862)
- Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association (2016), American Heart Association (Circulation 2016;133(9):916-947)
- Sex and Race/Ethnicity-Related Disparities in Care and Outcomes After Hospitalization for Coronary Artery Disease Among Older Adults (2016), Circulation: Cardiovascular Quality and Outcomes 2016;9(2 Suppl 1):S36-S44 (Get With The Guidelines-Coronary Artery Disease)
- Depression and Coronary Heart Disease: Recommendations for Screening, Referral, and Treatment: A Science Advisory From the American Heart Association (2008), American Heart Association (Circulation 2008;118(17):1768-1775)
- Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: A Scientific Statement From the American Heart Association (2014), American Heart Association (Circulation 2014;129(12):1350-1369)
- Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association (2020), American Heart Association (Circulation 2020;142(25):e506-e532)
- CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and acute myocardial infarction monographs (2026), Aether Forge
